Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rieks

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Blood|June 15, 1997
Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathwayT Syrovets, B Tippler, M Rieks, et al.
Deutsche Medizinische Wochenschrift (1946)|November 8, 1996
[Causal therapy of multiple sclerosis]D Pöhlau, M Rieks, T Postert, et al.
Acta Neurologica Scandinavica|November 7, 2001
Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetateO Aktas, N Ari, M Rieks, et al.
Journal of Clinical Apheresis|January 1, 1997
Photopheresis--a possible treatment of multiple sclerosis?: report of two casesD Poehlau, M Rieks, T Postert, et al.
Vox Sanguinis|April 15, 2000
Therapeutic immunoadsorption increases the level of circulating soluble HLA moleculesD Poehlau, U Kiltz, M Rieks, et al.
Fortschritte Der Medizin|November 10, 1996
[Mechanisms of action of intravenous immunoglobulins]D Poehlau, T Postert, M Rieks, et al.
European Journal of Neurology|June 27, 2006
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot studyS Schimrigk, N Brune, K Hellwig, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Blood|June 15, 1997
Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathwayT Syrovets, B Tippler, M Rieks, et al.
Deutsche Medizinische Wochenschrift (1946)|November 8, 1996
[Causal therapy of multiple sclerosis]D Pöhlau, M Rieks, T Postert, et al.
Acta Neurologica Scandinavica|November 7, 2001
Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetateO Aktas, N Ari, M Rieks, et al.
Journal of Clinical Apheresis|January 1, 1997
Photopheresis--a possible treatment of multiple sclerosis?: report of two casesD Poehlau, M Rieks, T Postert, et al.
Vox Sanguinis|April 15, 2000
Therapeutic immunoadsorption increases the level of circulating soluble HLA moleculesD Poehlau, U Kiltz, M Rieks, et al.
Fortschritte Der Medizin|November 10, 1996
[Mechanisms of action of intravenous immunoglobulins]D Poehlau, T Postert, M Rieks, et al.
European Journal of Neurology|June 27, 2006
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot studyS Schimrigk, N Brune, K Hellwig, et al.
Pageof 1